Director sold ~$77K of Axon Enterprise
Scheduled in advanceLoading…
Traded Feb 25, 2026 · Filed Feb 26, 2026
The boss of Axon Enterprise sold $5M of Axon Enterprise shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$5,002,400
Shares × reported transaction price
1 day after results of Feb 24, 2026, 70 days before results of May 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $520.18 on Feb 25, 2026, 30% above its 52-week low and 40% below its high, after an 18% drop over the previous 30 trading days
52-week range $399.65 (Feb 5, 2026) to $870.97 (Aug 7, 2025), 26% of the way up, from 251 adjusted closes. 30 trading days earlier: $631.73 on Jan 12, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Feb 17, 2026 in the U.S. District Court, District of Columbia. A filing is an allegation, not a finding.
NATHAN CUMMINGS FOUNDATION, INC. v. AXON ENTERPRISE, INC., docket 1:26-cv-00501, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.8% | -2.0% | +7.8% |
| 30 days | -23.5% | -7.9% | -15.6% |
| 90 days | -19.0% | +10.0% | -29.0% |
| 180 days | +12.0% | +11.7% | +0.3% |
Past results only. Not a forecast.
Director sold ~$77K of Axon Enterprise
Scheduled in advance2,144 → 1,946 shares held−9% of their stake
A board member of Axon Enterprise sold $100K of Axon Enterprise shares. Nobody planned it ahead of time.
250K → 242K shares held−3% of their stake
Axon Enterprise's PRESIDENT sold $3.92M of Axon Enterprise shares. Nobody planned it ahead of time.
